As EGFR mutant lung cancer patients survive longer because of the use of EGFR-TKIs, it would be unclear whether EGFR mutant lung cancer patients have BM due to their longer observation period or because EGFR mutant cancer cells tend to invade the brain. The gene discussed is EGFR; the disease is cancer.